Reportable: All News

Droedp5rqacyln6ubrvc

Kannalife Announces Completion of Name Change, Ticker Symbol Change

Doylestown, PA - January 16, 2019 – Kannalife, Inc. (“Kannalife”) (OTC: KLFE), a bio-pharmaceutical and phyto-medical company, is pleased to announce that the Company’s name change from TYG Solutions Corp. to Kannalife, Inc. and the change of ticker symbol to “KLFE” has been r...

View full release
84yapinsyml4sdev90az

Miami-Dade Police Department’s Real-Time Crime Center Chooses In-telligent to Keep Schools Notified and Informed in Emergency Situations

Chicago, IL – January 16, 2019 -- In-telligent, provider of a personal safety and emergency communications platform designed to keep individuals safe during emergency situations and time-sensitive events, today announced a partnership with Miami-Dade Police Department’s Real-T...

View full release
Idoqeuczq6aaxvvdf5ea

FDA Issues 510(k) Clearance to Applied Tissue Technologies’ Platform Wound Dressing (PWD®), A New Negative Pressure Wound Therapy System Without Foam or Gauze

Hingham, MA -- January 14, 2018 -- Applied Tissue Technologies (ATT), an advanced wound care company, announced US FDA 510(k) clearance of its Negative Pressure Wound Therapy product, the Platform Wound Dressing (PWD®). Classified by the FDA as a class II device, the patented ...

View full release
Tpc4pyaurbuuiidjdaeb

NexOptic’s DoubleTake™ Awarded “Top Tech of CES 2019” for Photography by Digital Trends

Vancouver, Canada – January 11, 2019 - NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE: NXO) (OTCQX: NXOPF) (FRANKFURT: E3O1) today announced that Digital Trends named DoubleTake, NexOptic’s “Binoculars Reimagined,” the “Top Tech of CES 2019” for photograp...

View full release
T08x1ua3s6kbhum1emfm

Laird Superfood Secures $32 Million in Private Funding Round

SISTERS, Ore., Jan. 11, 2019 -- Laird Superfood, maker of assorted superfood products, secured $32 millioni n a private funding round that included WeWork as an investor. This latest round of funding will support an increase in product development, acquisitions and significant...

View full release
V5gudwurrn6wg2vfsrap

PR Club Opens Call for Entries for 51st Annual Bell Ringer Awards

BOSTON — Jan. 9, 2019 — PR Club, the longest-standing association for communication professionals in New England, today opened submissions for the 51st Annual Bell Ringer Awards. The PR Club’s board of directors invites any and all public relations, marketing and communication...

View full release
Mwh2az6rbyypjczhkrtg

Kerastem and Myungmoon Bio Partner to Commercialize Stem Cell Hair Growth Technology

SOLANA BEACH, CA -- JANUARY 08, 2019 -- Kerastem, the global leader in the development and commercialization of regenerative medicine-based approaches to hair growth and Myungmoon Bio Co, LTD a healthcare company focused on bringing innovative regenerative therapies to market,...

View full release
9l737ck8thwm3kmwfqt6

Onelink® by First Alert® Portfolio Expansion Opens Up Unrivaled Experiences in 2019

Products Build on Each Other to Deliver Safety and Security from Trusted Industry Leader January, 7, 2019 -- Las Vegas, NV --Sands Expo #42316 – Welcome to the next level of home. With new connected home offerings that feature easy integration with each other and unparalleled ...

View full release
Zfn2x2drsqq0jjkwgicq

Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies for the Treatment of Cancer

September 4, 2019 -- Seattle, WA -- Adaptive Biotechnologies, an immune-driven medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech, a member of the Roche Group, to develop, manufacture and commercialize novel...

View full release
Ombodumaqbiskaqzjoq8

FDA Grants De Novo Marketing Authorization to First-of-its-Kind Device for Objectively Assessing Patients at Risk of Pressure Ulcers

BBI’s SEM Scanner “Challenges Everything We Know About Pressure Ulcer Management,” Current User in U.K. Says[i] LOS ANGELES and MANCHESTER, U.K., January 3, 2019-- Bruin Biometrics, LLC (“BBI”) has been granted U.S. Food and Drug Administration (FDA) marketing authorization fo...

View full release